Open-source ecosystem for in vitro and microphysiological systems
Menu

About

AboutGovernanceResponsible DataSecurity & PrivacyPolicies

Data

Data LibraryFind Data

Contribute

On-RampSubmit DataContributor MetadataDashboard

Tools

ToolsOpen SourceDevelopersSandboxGitHub

Learning & Community

Learning NetworkResourcesNews and EventsCommunityFor IndustryContact
Save the DateDecember 1-2, 2026Charlotte, North Carolina12th Annual Regenerative Manufacturing Innovation Consortium (RegMIC) Meeting: A Roadmap for Tissue Organoids and Body-on-a-Chip Manufacturing Standards
About MOSSDOAbout RegMICAbout the RegMIC 2026 meeting
Back to Home

Standards Exchange

A Shared Space for Standards Alignment and Implementation

PhysioVerse helps connect community needs, roadmap-informed priorities, implementation resources, and formal or emerging standards activities.

Purpose

Support implementation without replacing formal standards activities

Standards Exchange organizes practical alignment resources: descriptor guidance, templates, example records, validation concepts, benchmarking needs, and interoperability discussions. It supports implementation while remaining complementary to formal standards development organizations.

View Standards Alignment

Activity areas

  • Organoid manufacturing standards alignment
  • Body-on-chip manufacturing practices
  • Sensing and analytical technologies
  • Shipping, storage, stability, and logistics
  • Benchmarking and validity testing
  • Interoperability and metadata exchange

Standards and manufacturing partners

MOSSDO and RegMIC

Connect with the organizations advancing consensus standards, validation, and regenerative manufacturing across the PhysioVerse ecosystem.

About MOSSDO

The Microphysiological and Organoid Systems Standards Development Organization (MOSSDO) is a federally funded multi-stakeholder initiative focused specifically on establishing consensus-based standards for organoids, microphysiological systems (MPS), and body-on-a-chip technologies. MOSSDO develops frameworks for reproducibility, validation, and interoperability, enabling these platforms to be more reliably adopted across research, regulatory, and translational settings. In coordination with enabling ecosystem efforts such as PhysioVerse, MOSSDO provides the standards foundation that supports data integration, comparability, and broader field-wide adoption.

About RegMIC

The Regenerative Manufacturing Innovation Consortium (RegMIC), founded in 2014, is a national initiative that brings together stakeholders from industry, academia, and government to advance the manufacturing, scale-up, and commercialization of regenerative technologies. Through cross-sector collaboration, RegMIC addresses key challenges in translation, including process development, regulatory alignment, and the establishment of best practices across cell, tissue, and advanced in vitro systems.